Endo International plc announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), is voluntarily recalling one lot of Treprostinil Injection 20mg/20mL (1mg/mL) to the consumer level. The product is being recalled due to the potential for the presence of silicone particulate | ||||
Tags: Recalls Par Pharmaceutical Issues Voluntary Nationwide Recall One Lot Treprostinil Injection Due Potential for Silicone Particulates the Product Solution | ||||
Rating: 0.00 (0 votes) Rate this article | ||||
Bookmark and share this news item: |
Enter comment